Published in Cancer Epidemiol Biomarkers Prev on June 30, 2009
Impact of a Gene Test for Susceptibility to Lung Cancer in Smokers | NCT01176383
Debating clinical utility. Public Health Genomics (2010) 1.41
Consumers' use of web-based information and their decisions about multiplex genetic susceptibility testing. J Med Internet Res (2010) 1.35
Nicotine vaccines: will smokers take a shot at quitting? Nicotine Tob Res (2010) 1.15
Causal beliefs about obesity and associated health behaviors: results from a population-based survey. Int J Behav Nutr Phys Act (2010) 1.11
Framing Nicotine Addiction as a "Disease of the Brain": Social and Ethical Consequences. Soc Sci Q (2011) 1.10
Patient compliance based on genetic medicine: a literature review. J Community Genet (2013) 1.04
Evaluation of a brief web-based genetic feedback intervention for reducing alcohol-related health risks associated with ALDH2. Ann Behav Med (2010) 1.00
Genetic susceptibility testing and readiness to control weight: Results from a randomized controlled trial. Obesity (Silver Spring) (2014) 0.88
Brief, instructional smokeless tobacco use among cigarette smokers who do not intend to quit: a pilot randomized clinical trial. Nicotine Tob Res (2013) 0.87
Translational Genomic Research: Protocol Development and Initial Outcomes following SNP Testing for Colon Cancer Risk. Transl Behav Med (2012) 0.86
Genetic test feedback with weight control advice: study protocol for a randomized controlled trial. Trials (2012) 0.86
Young smokers' views of genetic susceptibility testing for lung cancer risk: minding unintended consequences. J Community Genet (2011) 0.86
Impact of genetic notification on smoking cessation: systematic review and pooled-analysis. PLoS One (2012) 0.85
Direct-to-patient disclosure of results of mismatch repair screening for Lynch syndrome via electronic personal health record: a feasibility study. Genet Med (2014) 0.82
Design and implementation of a randomized controlled trial of genomic counseling for patients with chronic disease. J Pers Med (2014) 0.81
Utility of genome-wide association study findings: prostate cancer as a translational research paradigm. J Intern Med (2012) 0.81
A mechanistic test of nicotine replacement therapy sampling for smoking cessation induction. Psychol Addict Behav (2014) 0.81
Integrating genetic studies of nicotine addiction into public health practice: stakeholder views on challenges, barriers and opportunities. Public Health Genomics (2011) 0.80
Concerns about unintended negative consequences of informing the public about multifactorial risks may be premature for young adult smokers. Br J Health Psychol (2013) 0.79
Outcomes of a Randomized Controlled Trial of Genomic Counseling for Patients Receiving Personalized and Actionable Complex Disease Reports. J Genet Couns (2017) 0.78
Predictors of patient uptake of colorectal cancer gene environment risk assessment. Genome Med (2012) 0.78
Young smokers' interpretations of the estimated lung cancer risk associated with a common genetic variant of low penetrance. Public Health Genomics (2014) 0.75
Genetic test to stop smoking (GeTSS) trial protocol: randomised controlled trial of a genetic test (Respiragene) and Auckland formula to assess lung cancer risk. BMC Pulm Med (2014) 0.75
Feasibility of using an epigenetic marker of risk for lung cancer, methylation of p16, to promote smoking cessation among US veterans. BMJ Open Respir Res (2014) 0.75
"I don't believe it." Acceptance and skepticism of genetic health information among African-American and White smokers. Soc Sci Med (2017) 0.75
The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict (1991) 63.91
A meta-analysis of fear appeals: implications for effective public health campaigns. Health Educ Behav (2000) 6.72
Understanding the potential of teachable moments: the case of smoking cessation. Health Educ Res (2003) 5.59
Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research. JAMA (1997) 5.47
Effectiveness of a large-scale distribution programme of free nicotine patches: a prospective evaluation. Lancet (2005) 3.29
The genome gets personal--almost. JAMA (2008) 3.28
Incorporating genetic susceptibility feedback into a smoking cessation program for African-American smokers with low income. Cancer Epidemiol Biomarkers Prev (2002) 2.26
Proposed model of the relationship of risk information seeking and processing to the development of preventive behaviors. Environ Res (1999) 1.93
Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk. Carcinogenesis (2002) 1.73
Genetic susceptibility testing in smoking-cessation treatment: one-year outcomes of a randomized trial. Addict Behav (1998) 1.68
Comparison processes in social judgment: mechanisms and consequences. Psychol Rev (2003) 1.68
Free nicotine patch giveaway program 12-month follow-up of participants. Am J Prev Med (2006) 1.66
Incorporating biomarkers of exposure and genetic susceptibility into smoking cessation treatment: effects on smoking-related cognitions, emotions, and behavior change. Health Psychol (1997) 1.62
Barriers and motivators to gaining access to smoking cessation services amongst deprived smokers--a qualitative study. BMC Health Serv Res (2006) 1.57
Psychological and behavioural impact of genetic testing smokers for lung cancer risk: a phase II exploratory trial. J Health Psychol (2008) 1.41
The impact of learning of a genetic predisposition to nicotine dependence: an analogue study. Tob Control (2003) 1.29
Does genetic testing result in behavioral health change? Changes in smoking behavior following testing for alpha-1 antitrypsin deficiency. Ann Behav Med (2007) 1.27
An intervention study of smoking cessation with feedback on genetic cancer susceptibility in Japan. Prev Med (2005) 1.27
Giving away free nicotine medications and a cigarette substitute (Better Quit) to promote calls to a quitline. J Public Health Manag Pract (2005) 1.25
The feasibility of online genetic testing for lung cancer susceptibility: uptake of a web-based protocol and decision outcomes. Genet Med (2008) 1.23
Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer Epidemiol Biomarkers Prev (1995) 1.11
Can genetic risk information enhance motivation for smoking cessation? An analogue study. Health Psychol (2006) 1.08
Associations between anticipated reactions to genetic test results and interest in genetic testing: will self-selection reduce the potential for harm? Genet Test (2008) 1.08
Maximizing the motivational impact of feedback of lung cancer susceptibility on smokers' desire to quit. J Health Commun (2000) 1.03
The impact of genetic testing for Crohn's disease, risk magnitude and graphical format on motivation to stop smoking: an experimental analogue study. Clin Genet (2008) 1.00
Genetic testing for heart disease susceptibility: potential impact on motivation to quit smoking. Clin Genet (2007) 1.00
Interpretation of genetic risk feedback among African American smokers with low socioeconomic status. Health Psychol (2004) 0.99
Effectiveness of biomedical risk assessment as an aid for smoking cessation: a systematic review. Tob Control (2007) 0.87
Genotype announcement to Japanese smokers who attended a health checkup examination. J Epidemiol (2006) 0.86
A pilot study on genotype announcement to induce smoking cessation by Japanese smokers. Asian Pac J Cancer Prev (2004) 0.81
DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer. N Engl J Med (2007) 8.28
Non-small cell lung cancer. J Natl Compr Canc Netw (2010) 3.93
Effect of clinical decision-support systems: a systematic review. Ann Intern Med (2012) 3.42
Understanding health behavior change among couples: an interdependence and communal coping approach. Soc Sci Med (2005) 3.41
Treatment success in cancer: new cancer treatment successes identified in phase 3 randomized controlled trials conducted by the National Cancer Institute-sponsored cooperative oncology groups, 1955 to 2006. Arch Intern Med (2008) 3.07
The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop. Genet Med (2009) 2.91
Racial diversity of actionable mutations in non-small cell lung cancer. J Thorac Oncol (2015) 2.80
Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung. Chest (2004) 2.73
Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer. Clin Cancer Res (2006) 2.68
Ribonucleotide reductase messenger RNA expression and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients. Clin Cancer Res (2004) 2.54
Main outcomes of the FRESH START trial: a sequentially tailored, diet and exercise mailed print intervention among breast and prostate cancer survivors. J Clin Oncol (2007) 2.50
Physician referral for fertility preservation in oncology patients: a national study of practice behaviors. J Clin Oncol (2009) 2.31
Incorporating genetic susceptibility feedback into a smoking cessation program for African-American smokers with low income. Cancer Epidemiol Biomarkers Prev (2002) 2.26
Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer. Clin Cancer Res (2005) 2.19
Computed tomography response, but not positron emission tomography scan response, predicts survival after neoadjuvant chemotherapy for resectable non-small-cell lung cancer. J Clin Oncol (2008) 2.18
Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancer. J Clin Oncol (2009) 2.13
Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis. J Clin Oncol (2008) 1.97
RRM1-induced metastasis suppression through PTEN-regulated pathways. Oncogene (2003) 1.95
ERCC1 expression is a predictor of survival in resected patients with non-small cell lung cancer. Chest (2005) 1.93
A tailored minimal self-help intervention to promote condom use in young women: results from a randomized trial. AIDS (2003) 1.93
Feasibility and efficacy of molecular analysis-directed individualized therapy in advanced non-small-cell lung cancer. J Clin Oncol (2007) 1.91
Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancer. Oncogene (2003) 1.88
Phase I/II study of the Src inhibitor dasatinib in combination with erlotinib in advanced non-small-cell lung cancer. J Clin Oncol (2010) 1.88
Overutilization of endoscopic surveillance in nondysplastic Barrett's esophagus: a multicenter study. Gastrointest Endosc (2011) 1.82
Participation in genetic testing research varies by social group. Public Health Genomics (2010) 1.79
Patients' understanding of and responses to multiplex genetic susceptibility test results. Genet Med (2012) 1.75
Active Mothers Postpartum: a randomized controlled weight-loss intervention trial. Am J Prev Med (2009) 1.71
Non-small cell lung cancer clinical practice guidelines in oncology. J Natl Compr Canc Netw (2006) 1.68
The self-efficacy of family caregivers for helping cancer patients manage pain at end-of-life. Pain (2003) 1.68
Suppression of lung tumor formation by the regulatory subunit of ribonucleotide reductase. Cancer Res (2006) 1.68
Enabling health care decisionmaking through clinical decision support and knowledge management. Evid Rep Technol Assess (Full Rep) (2012) 1.68
Effects of genetic risk information on children's psychosocial wellbeing: a systematic review of the literature. Genet Med (2010) 1.65
Too many referrals of low-risk women for BRCA1/2 genetic services by family physicians. Cancer Epidemiol Biomarkers Prev (2008) 1.64
Thyroid transcription factor 1 is an independent prognostic factor for patients with stage I lung adenocarcinoma. J Clin Oncol (2008) 1.61
Contingent monetary reinforcement of smoking reductions, with and without transdermal nicotine, in outpatients with schizophrenia. Exp Clin Psychopharmacol (2002) 1.58
Effects of a mammography decision-making intervention at 12 and 24 months. Am J Prev Med (2002) 1.55
Assessing hypothetical scenario methodology in genetic susceptibility testing analog studies: a quantitative review. Genet Med (2007) 1.52
Relationship between tumor size and survival among patients with resection of multiple synchronous lung cancers. J Thorac Oncol (2010) 1.50
Age-related vulnerabilities of older adults with colon adenomas: evidence from Project Prevent. Cancer (2004) 1.48
Malignant pleural mesothelioma: a comprehensive review. Cancer Control (2006) 1.47
Proteomic contributions to personalized cancer care. Mol Cell Proteomics (2008) 1.46
Development of a Theoretically Driven mHealth Text Messaging Application for Sustaining Recent Weight Loss. JMIR Mhealth Uhealth (2013) 1.45
Nicotine replacement and behavioral therapy for smoking cessation in pregnancy. Am J Prev Med (2007) 1.44
The interaction of post-traumatic growth and post-traumatic stress symptoms in predicting depressive symptoms and quality of life. Psychooncology (2008) 1.37
Consumers' use of web-based information and their decisions about multiplex genetic susceptibility testing. J Med Internet Res (2010) 1.35
Personal utility and genomic information: look before you leap. Genet Med (2009) 1.32
The guinea pig syndrome: improving clinical trial participation among thoracic patients. J Thorac Oncol (2007) 1.31
Association between health-service use and multiplex genetic testing. Genet Med (2012) 1.29
Project PREVENT: a randomized trial to reduce multiple behavioral risk factors for colon cancer. Cancer Epidemiol Biomarkers Prev (2005) 1.28
Lung cancer. Practice organization. Chest (2003) 1.27
Active Mothers Postpartum (AMP): rationale, design, and baseline characteristics. J Womens Health (Larchmt) (2008) 1.27
A systematic review of quality of life associated with standard chemotherapy regimens for advanced non-small cell lung cancer. J Thorac Oncol (2007) 1.25
Upregulation of the tissue inhibitor of metalloproteinase-1 protein is associated with progression of human non-small-cell lung cancer. J Clin Oncol (2004) 1.23
The feasibility of online genetic testing for lung cancer susceptibility: uptake of a web-based protocol and decision outcomes. Genet Med (2008) 1.23
Frequency and type of epidermal growth factor receptor mutations in African Americans with non-small cell lung cancer. J Thorac Oncol (2011) 1.23
Perceptions of patients' self-efficacy for managing pain and lung cancer symptoms: correspondence between patients and family caregivers. Pain (2002) 1.22
Blazing a trail: a public health research agenda in genomics and chronic disease. Prev Chronic Dis (2005) 1.21
Nuclear excision repair-based personalized therapy for non-small cell lung cancer: from hypothesis to reality. Int J Biochem Cell Biol (2007) 1.19
Parents' attitudes toward pediatric genetic testing for common disease risk. Pediatrics (2011) 1.18
Persistent smoking after a diagnosis of lung cancer is associated with higher reported pain levels. J Pain (2009) 1.18
Enzastaurin, an oral serine/threonine kinase inhibitor, as second- or third-line therapy of non-small-cell lung cancer. J Clin Oncol (2008) 1.17
Regular aspirin use and lung cancer risk. BMC Cancer (2002) 1.15
Thymidylate synthase in situ protein expression and survival in stage I nonsmall-cell lung cancer. Cancer (2008) 1.15
Preferences for genetic and behavioral health information: the impact of risk factors and disease attributions. Ann Behav Med (2010) 1.13
Prostate cancer in African Americans: relationship of patient and partner self-efficacy to quality of life. J Pain Symptom Manage (2004) 1.13
Multi-level targeting of the phosphatidylinositol-3-kinase pathway in non-small cell lung cancer cells. PLoS One (2012) 1.12
Obtaining DNA from a geographically dispersed cohort of current and former smokers: use of mail-based mouthwash collection and monetary incentives. Nicotine Tob Res (2004) 1.11
ID1 facilitates the growth and metastasis of non-small cell lung cancer in response to nicotinic acetylcholine receptor and epidermal growth factor receptor signaling. Mol Cell Biol (2011) 1.11
Patient-provider communication and perspectives on smoking cessation and relapse in the oncology setting. Patient Educ Couns (2009) 1.11
The VA Women's Health Practice-Based Research Network: amplifying women veterans' voices in VA research. J Gen Intern Med (2013) 1.09
A randomized trial comparing the effects of self-help materials and proactive telephone counseling on teen smoking cessation. Health Psychol (2004) 1.09
The association of beliefs about heredity with preventive and interpersonal behaviors in communities affected by podoconiosis in rural Ethiopia. Am J Trop Med Hyg (2012) 1.08
Retention and use of breast cancer recurrence risk information from genomic tests: the role of health literacy. Cancer Epidemiol Biomarkers Prev (2007) 1.08
Testing the interaction between parent-child relationship factors and parent smoking to predict youth smoking. J Adolesc Health (2004) 1.08
Daily affective reactivity as a prospective predictor of depressive symptoms. J Pers (2005) 1.07
Prevalence and predictors of multiple behavioral risk factors for colon cancer. Prev Med (2005) 1.07
Immersive virtual environment technology: a promising tool for future social and behavioral genomics research and practice. Health Commun (2009) 1.05
Phase II study of first-line sequential chemotherapy with gemcitabine-carboplatin followed by docetaxel in patients with advanced non-small cell lung cancer. Oncology (2005) 1.02
Challenges and solutions for recruiting pregnant smokers into a nicotine replacement therapy trial. Nicotine Tob Res (2006) 1.01
Translating biomarkers into clinical practice: prognostic implications of cyclophilin A and macrophage migratory inhibitory factor identified from protein expression profiles in non-small cell lung cancer. Lung Cancer (2004) 1.01
Phase I/II study of atrasentan, an endothelin A receptor antagonist, in combination with paclitaxel and carboplatin as first-line therapy in advanced non-small cell lung cancer. Clin Cancer Res (2008) 1.01
EGR1 predicts PTEN and survival in patients with non-small-cell lung cancer. J Clin Oncol (2005) 1.01
Does this woman have osteoporosis? JAMA (2004) 1.00
Reminder letter, tailored stepped-care, and self-choice comparison for repeat mammography. Am J Prev Med (2003) 1.00
A qualitative study exploring barriers related to use of footwear in rural highland ethiopia: implications for neglected tropical disease control. PLoS Negl Trop Dis (2013) 1.00
Interpretation of genetic risk feedback among African American smokers with low socioeconomic status. Health Psychol (2004) 0.99
Factors associated with annual-interval mammography for women in their 40s. Cancer Epidemiol (2009) 0.99
Retracted A small molecule inhibits Akt through direct binding to Akt and preventing Akt membrane translocation. J Biol Chem (2010) 0.98
Phase 2 trial of docetaxel and gefitinib in the first-line treatment of patients with advanced nonsmall-cell lung cancer (NSCLC) who are 70 years of age or older. Cancer (2008) 0.98